Novartis AG
NVS
$125.50
$0.490.39%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.03% | 6.20% | |||
| Total Other Revenue | -42.58% | 102.07% | |||
| Total Revenue | -3.22% | 8.93% | |||
| Cost of Revenue | 6.51% | 2.95% | |||
| Gross Profit | -6.03% | 10.78% | |||
| SG&A Expenses | -3.98% | 12.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 1,850.00% | -102.70% | |||
| Total Operating Expenses | 4.28% | 6.51% | |||
| Operating Income | -16.09% | 13.34% | |||
| Income Before Tax | -7.39% | 2.81% | |||
| Income Tax Expenses | -47.53% | -36.47% | |||
| Earnings from Continuing Operations | -2.34% | 11.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -111.76% | 666.67% | |||
| Net Income | -2.80% | 12.06% | |||
| EBIT | -16.09% | 13.34% | |||
| EBITDA | -11.91% | 11.01% | |||
| EPS Basic | -1.68% | 13.21% | |||
| Normalized Basic EPS | -16.34% | 14.18% | |||
| EPS Diluted | -1.94% | 13.19% | |||
| Normalized Diluted EPS | -16.43% | 14.11% | |||
| Average Basic Shares Outstanding | -1.13% | -1.02% | |||
| Average Diluted Shares Outstanding | -1.02% | -0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -0.58% | |||